1st EQIPD Newsletter
The first Newsletter by the EQIPD consortium can be found HERE.
The EQIPD Quality System is the result of a collaborative effort between several people and organizations, yet cannot specifically address all potential scenarios under which research rigor measures are needed and will be implemented. The foundation laid by EQIPD is formulated in the “core requirements” (see link below) and we welcome further efforts to support…
The Guarantors of EQIPD Society is honored to receive a Sponsorship grant from Cohen Veterans Bioscience, a U.S.-based 501c3 public charity to support our critical work in driving quality and reproducibility of research. CVB has supported the EQIPD Consortium from its inception and is also a Founding Member of the Society. This funding will support…
Our book on quality in preclinical research, including many articles from authors within the EQIPD consortium, has just been published: Bespalov A, Michel MC, Steckler T (eds) Handbook of Experimental Pharmacology – Good Research Practice in Non-Clinical Pharmacology and Biomedicine, Springer Open, Cham, Switzerland. ISBN 978-3-030-33655-4, eBook ISBN 978-3-030-33656-1 (2020). Access the book HERE.
Members of the EQIPD consortium have identified and published 5 Domains for increasing rigour in animal experiments. The 5 Domains are published in Nature Methods and very well supplement the concept of the EQIPD quality system. Read about the EQIPD QS in our eLife publication The domains are summarised below and a more detailed overview…
The Research Transparency Tool was developed by the EQIPD Consortium Taskforce and implemented online with support from a SBIR award from the NIH: https://public-funding-tool.paasp.net/survey The tool creates a “snapshot” of the environment in which research is conducted and is meant to help funders and applicants align on relevant quality expectations. More information in the EQIPD…
Check out the updates on the outcome of the Alzheimer systematic review, the EQIPD brainstorming session at ECNP, and more in the newest version of our newsletter! Read the Newsletter here.